Trial Profile
Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Apr 2019
Price :
$35
*
At a glance
- Drugs Dapsone (Primary)
- Indications Acne vulgaris
- Focus Pharmacokinetics
- Sponsors Allergan
- 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Feb 2013 New trial record